Journal
CANCER CELL
Volume 22, Issue 4, Pages 425-437Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2012.08.024
Keywords
-
Categories
Funding
- German Cancer Aid [109252, 108456]
- BMBF [01GS0883]
- Koningin Wilhelmina Fonds [UvA-2010-4713]
- KIKA
- Cole Foundation
- Canadian Institute of Health Research
- Institute of Cancer Research
- Genome Canada
- Genome Quebec
- Alfred-Muller Award for Neuro-Oncology
- The Brain Tumour Charity [10/106] Funding Source: researchfish
Ask authors/readers for more resources
Glioblastoma (GBM) is a brain tumor that carries a dismal prognosis and displays considerable heterogeneity. We have recently identified recurrent H3F3A mutations affecting two critical amino acids (K27 and G34) of histone H3.3 in one-third of pediatric GBM. Here, we show that each H3F3A mutation defines an epigenetic subgroup of GBM with a distinct global methylation pattern, and that they are mutually exclusive with IDH1 mutations, which characterize a third mutation-defined subgroup. Three further epigenetic subgroups were enriched for hallmark genetic events of adult GBM and/or established transcriptomic signatures. We also demonstrate that the two H3F3A mutations give rise to GBMs in separate anatomic compartments, with differential regulation of transcription factors OLIG1, OLIG2, and FOXG1, possibly reflecting different cellular origins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available